Clinics in Dermatology
Volume 25, Issue 6 , Pages 555-562 , November 2007

Childhood psoriasis

  • Sandrine Benoit, MD
    • ,
  • Henning Hamm, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 931 201 26738, +49 931 201 26353 (secr.); fax: +49 931 201 26462.

References 

  1. Faber E, Nall M. The natural history of psoriasis in 5600 patients. Dermatologica. 1974;148:1–18
  2. Swanbeck G, Inerot A, Martinsson T, et al. Age at onset and different types of psoriasis. Br J Dermatol. 1995;133:768–773
  3. Kumar B, Jain R, Sandhu K, et al. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol. 2004;43:654–658
  4. Nyfors A, Lemholt K. Psoriasis in children. A short review and a survey of 245 cases. Br J Dermatol. 1975;92:437–442
  5. al-Fouzan AS, Nanda A. A survey of childhood psoriasis in Kuwait. Pediatr Dermatol. 1994;11:116–119
  6. Morris A, Rogers M, Fischer G, et al. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol. 2001;18:188–198
  7. Schafer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology. 2006;212:327–337
  8. Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17:174–178
  9. Lomholt G. In: Prevalence, spontaneous course and genetics—a census study on the prevalence of skin disease on the Faröe Islands. Copenhagen: GEC GAD; 1963;p. 157–184
  10. Henseler T. The genetics of psoriasis. J Am Acad Dermatol. 1997;37:S1–S11
  11. Nanda A, Kaur S, Kaur I, et al. Childhood psoriasis: an epidemiologic survey of 112 patients. Pediatr Dermatol. 1990;7:19–21
  12. Atherton DJ, Kahana M, Russell-Jones R. Naevoid psoriasis. Br J Dermatol. 1989;120:837–841
  13. Honig PJ. Guttate psoriasis associated with perianal streptococcal disease. J Pediatr. 1988;113:1037–1039
  14. Liao PB, Rubinson R, Howard R, et al. Annular pustular psoriasis—most common form of pustular psoriasis in children: report of three cases and review of the literature. Pediatr Dermatol. 2002;19:19–25
  15. Juanqin G, Zhiqiang C, Zijia H. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. Pediatr Dermatol. 1998;15:144–146
  16. Zelickson BD, Muller SA. Generalized pustular psoriasis in childhood. Report of thirteen cases. J Am Acad Dermatol. 1991;24:186–194
  17. Espinoza LR, Cuellar ML, Silveira LH. Psoriatic arthritis. Curr Opin Rheumatol. 1992;4:470–478
  18. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003;4:441–447
  19. Southwood TR, Petty RE, Malleson PN, et al. Psoriatic arthritis in children. Arthritis Rheum. 1989;32:1007–1013
  20. Shore A, Ansell BM. Juvenile psoriatic arthritis—an analysis of 60 cases. J Pediatr. 1982;100:529–535
  21. Johnson TM, Duvic M, Rapini RP, et al. AIDS exacerbates psoriasis. N Engl J Med. 1985;313:1415
  22. Lazar AP, Roenigk HH. Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasis. J Am Acad Dermatol. 1988;18:144
  23. Cassandra M, Conte E, Cortez B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and review of the literature. Pediatr Dermatol. 2003;20:506–510
  24. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol. 2000;1:159–165
  25. Wolf R, Ruocco V. Triggered psoriasis. Adv Exp Med Biol. 1999;455:221–225
  26. O'Brien M, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol. 2006;5:426–432
  27. Picardi A, Mazzotti E, Gaetano P, et al. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics. 2005;46:556–564
  28. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic diseases. Br J Dermatol. 2006;155:145–151
  29. Zappel K, Sterry W, Blume-Peytavi U. Therapy options for psoriasis in childhood and adolescence. J Dtsch Dermatol Ges. 2004;2:329–342
  30. Wilson JK, Al-Suwaidan SN, Krowchuk D, et al. Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy?. Pediatr Dermatol. 2003;20:11–15
  31. Zvulunov A, Anisfeld A, Metzker A. Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol. 1994;33:808–810
  32. Klem EB. Effects of antipsoriatic drugs and metabolic inhibitors on the growth of epidermal cells in culture. J Invest Dermatol. 1978;70:27–32
  33. Park SB, Suh DH, Youn JI. A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis. Pediatr Dermatol. 1999;16:321–325
  34. Darley CR, Cunliffe WJ, Green CM, et al. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris. Br J Dermatol. 1996;135:390–393
  35. Oranje AP, Marcoux D, Svensson A, et al. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol. 1997;36:203–208
  36. Lebwohl M, Siskin SB, Epinette W, et al. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol. 1996;35:268–269
  37. Lebwohl M, Yoles A, Lombardi K, et al. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. J Am Acad Dermatol. 1998;39:447–450
  38. Kragballe K, Austad J, Barnes L, et al. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris. Br J Dermatol. 2006;154:1155–1160
  39. Kragballe K, Barnes L, Hamberg KJ, et al. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol. 1998;139:649–654
  40. Ortonne JP, van de Kerkhof PC, Prinz JC, et al. 0.3% tacrolimus gel and 0.5% tacrolimus cream show efficacy in mild to moderate plaque psoriasis: results of a randomized, open-label, observer-blinded study. Acta Derm Venereol. 2006;86:29–33
  41. Wohlrab J. Calcineurin inhibitors for topical therapy in psoriasis. Hautarzt. 2006;57:661–665
  42. Steele JA, Choi C, Kwong PC. Topical tacrolimus in the treatment of inverse psoriasis in children. J Am Acad Dermatol. 2005;53:713–716
  43. Jury CS, McHenry P, Burden AD, et al. Narrowband ultraviolet B (UVB) phototherapy in children. Clin Exp Dermatol. 2006;31:196–199
  44. Pasic A, Ceovic R, Lipozencic J, et al. Phototherapy in pediatric patients. Pediatr Dermatol. 2003;20:71–77
  45. Dawe RS, Cameron H, Yule S, et al. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol. 2003;148:1194–1204
  46. Kopp T, Karlhofer F, Szepfalusi Z, et al. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis, von Zumbusch type. Br J Dermatol. 2004;151:912–916
  47. Rosinska D, Wolska H, Jablonska S, et al. Etretinate in severe psoriasis of children. Pediatr Dermatol. 1988;5:266–272
  48. Shelnitz LS, Esterly NB, Honig PJ. Etretinate therapy for generalized pustular psoriasis in children. Arch Dermatol. 1987;123:230–233
  49. Lowe NJ, Prystowsky JH, Bourget T, et al. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol. 1991;24:591–594
  50. Ruzicka T, Sommerburg C, Braun-Falco O, et al. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. Arch Dermatol. 1990;126:482–486
  51. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol. 2003;49:171–182
  52. Ruiz-Maldonado R, Tamayo-Sanchez L, Orozco-Covarrubias ML. The use of retinoids in the pediatric patient. Dermatol Clin. 1998;16:553–569
  53. Kumar B, Dhar S, Handa S, et al. Methotrexate in childhood psoriasis. Pediatr Dermatol. 1994;11:271–273
  54. Dogra S, Handa S, Kanwar AJ. Methotrexate in severe childhood psoriasis. Pediatr Dermatol. 2004;21:283–284
  55. Dadlani C, Orlow SJ. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature. J Am Acad Dermatol. 2005;52:316–340
  56. Salim A, Tan E, Ilchyshyn A, et al. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Br J Dermatol. 2006;154:1169–1174
  57. Lebwohl M, Ellis C, Gottlieb A, et al. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol. 1998;39:464–475
  58. Mahe E, Bodemer C, Pruszkowski A, et al. Cyclosporine in childhood psoriasis. Arch Dermatol. 2001;137:1532–1533
  59. Perrett CM, Ilchyshyn A, Berth-Jones J. Cyclosporin in childhood psoriasis. J Derm Treat. 2003;14:113–118
  60. Cooney GF, Habucky K, Hoppu K. Cyclosporin pharmacokinetics in paediatric transplant recipients. Clin Pharmacokinet. 1997;32:481–495
  61. Mrowietz U. Concepts of the mechanisms of action of cyclosporin in psoriasis. A review with guidelines on therapy. Hautarzt. 1993;44:353–360
  62. Papoutsaki M, Costanzo A, Massotta A, et al. Etanercept for the treatment of severe childhood psoriasis. Br J Dermatol. 2006;154:181–183
  63. Hawrot AC, Metry DW, Theos AJ, et al. Etanercept for psoriasis in the pediatric population: experience in nine patients. Pediatr Dermatol. 2006;23:67–71
  64. Menter MA, Cush JM. Successful treatment of pediatric psoriasis with infliximab. Pediatr Dermatol. 2004;21:87–88

PII: S0738-081X(07)00153-8

doi: 10.1016/j.clindermatol.2007.08.009

Clinics in Dermatology
Volume 25, Issue 6 , Pages 555-562 , November 2007

Article Tools

* Image Usage & Resolution